KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Non-Current Debt (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Non-Current Debt data on record, last reported at $6.9 billion in Q4 2025.

  • For Q4 2025, Non-Current Debt rose 29.77% year-over-year to $6.9 billion; the TTM value through Dec 2025 reached $6.9 billion, up 29.77%, while the annual FY2025 figure was $6.9 billion, 29.77% up from the prior year.
  • Non-Current Debt reached $6.9 billion in Q4 2025 per ZBH's latest filing, down from $7.5 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $7.5 billion in Q3 2025 and bottomed at $3.1 million in Q1 2021.
  • Average Non-Current Debt over 5 years is $5.3 billion, with a median of $5.2 billion recorded in 2023.
  • Peak YoY movement for Non-Current Debt: crashed 99.96% in 2021, then surged 170425.81% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $5.5 billion in 2021, then fell by 5.7% to $5.2 billion in 2022, then dropped by 5.52% to $4.9 billion in 2023, then grew by 9.73% to $5.3 billion in 2024, then increased by 29.77% to $6.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $6.9 billion in Q4 2025, $7.5 billion in Q3 2025, and $6.8 billion in Q2 2025.